0Q6H logo

Hofseth BioCare LSE:0Q6H Stock Report

Last Price

NOK 1.61

Market Cap

NOK 631.0m

7D

n/a

1Y

n/a

Updated

22 Dec, 2024

Data

Company Financials

0Q6H Stock Overview

Operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. More details

0Q6H fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Hofseth BioCare ASA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hofseth BioCare
Historical stock prices
Current Share PriceNOK 1.61
52 Week HighNOK 2.16
52 Week LowNOK 1.61
Beta0.36
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-52.88%

Recent News & Updates

Recent updates

Shareholder Returns

0Q6HGB BiotechsGB Market
7Dn/a-4.2%-2.6%
1Yn/a-24.5%2.4%

Return vs Industry: Insufficient data to determine how 0Q6H performed against the UK Biotechs industry.

Return vs Market: Insufficient data to determine how 0Q6H performed against the UK Market.

Price Volatility

Is 0Q6H's price volatile compared to industry and market?
0Q6H volatility
0Q6H Average Weekly Movementn/a
Biotechs Industry Average Movement6.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0Q6H's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0Q6H's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200070Jon Odegardwww.hofsethbiocare.com

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Hofseth BioCare ASA Fundamentals Summary

How do Hofseth BioCare's earnings and revenue compare to its market cap?
0Q6H fundamental statistics
Market capNOK 631.01m
Earnings (TTM)-NOK 133.48m
Revenue (TTM)NOK 248.08m

2.5x

P/S Ratio

-4.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0Q6H income statement (TTM)
RevenueNOK 248.08m
Cost of RevenueNOK 187.72m
Gross ProfitNOK 60.36m
Other ExpensesNOK 193.83m
Earnings-NOK 133.48m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 14, 2025

Earnings per share (EPS)-0.32
Gross Margin24.33%
Net Profit Margin-53.80%
Debt/Equity Ratio189.8%

How did 0Q6H perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:21
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hofseth BioCare ASA is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jonas PeciulisNorne Securities AS
Henning SteffenrudSwedbank Norway